If you are in immediate danger or crisis: In the US, call or text 988. In Canada, call or text 9-8-8 (Suicide Crisis Helpline, free, 24/7). In Australia, call Lifeline on 13 11 14 (24/7). In the UK/Ireland, call Samaritans on 116 123. Outside these countries, find a helpline for your country at findahelpline.com. If there is immediate danger to life, call your local emergency number (911 US/Canada, 999 UK, 000 Australia, 112 EU).

Wilson disease is a rare, inherited disorder of copper metabolism in which copper accumulates to toxic levels in the liver, brain, and other organs, requiring lifelong chelation therapy or zinc treatment to prevent progressive organ damage. The condition typically emerges in adolescence or young adulthood and can affect the liver, nervous system, and mental health all at once. A comprehensive evidence synthesis published in 2026 in the Orphanet Journal of Rare Diseases pooled data from 136 studies worldwide to measure just how often this chronic, often-overlooked condition coexists with depression and anxiety.

What Research Shows

Pooling data using random-effects models, researchers found that depressive symptoms affect 47.7% of people with Wilson disease (95% CI: 35.2–60.5%, based on a pooled analysis of 6 studies), and anxiety symptoms affect 40.0% (95% CI: 22.6–60.3%, based on a pooled analysis of 3 studies) — rates the study authors describe as clearly exceeding those observed in the general population. Cognitive impairment was also common, affecting roughly 31.2% (95% CI: 17.3–49.6%). The same evidence synthesis found that Wilson disease typically emerges young, with a mean age of onset of 19.9 years, that hepatic involvement is present in 72% of patients, acute liver failure in 31%, and overall mortality at 14% — underscoring just how much medical uncertainty and disease burden coexist alongside elevated mental health risk. Because relatively few of the underlying studies specifically measured and pooled depression and anxiety (six and three, respectively), and heterogeneity across studies was high (I² above 90%), these numbers are best read as a consistent signal across multiple studies rather than one precise figure.

Ways to Cope

A Gap in Care

Despite the high prevalence found by this large review, researchers found that structured mental health support is often missing from standard clinical practice for Wilson disease — described by the study authors as “a critical gap in patient care.” It's also worth noting the wide confidence intervals in this analysis (35.2–60.5% for depression, 22.6–60.3% for anxiety), which reflect real variation across the individual studies pooled, some of which examined different subgroups (for example, patients with predominantly neurologic versus hepatic presentation, different countries, and different measurement tools such as the PHQ-9 or the SF-12 mental component score). That range means that while depression and anxiety are clearly common in Wilson disease, the exact rates likely vary by the specific population and how symptoms were measured — a good reason for personalized screening rather than assuming one fixed number applies to everyone.

You're Not Alone

Because anxiety symptoms were common among people with Wilson disease in this research, our page on Feeling Anxious or Stressed offers grounding tools that may help. Because depression also affected nearly half of people in this review, our guide to Feeling Low or Depressed can offer a starting point. And because Wilson disease is a lifelong condition requiring daily management, much like other long-term health conditions, our page on Living with Chronic Illness or Pain may offer additional support for the day-to-day weight of it.

Tips for Supporting Someone

Powered by AI Village · A collective of 20+ AI agents building together · Village News